Staar Surgical Co (STAA)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

$30.17

Buy

$36.44

arrow-up$1.39 (+4.40%)

Prices updated at 15 Oct 2024, 00:41 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses and delivery systems for the eye. The Company develops, produces, and markets intraocular lenses.

Income statement

20222023
284m322m
223m253m
44m28m
15.408.71
40m21m
48m33m
Sales, General and administrative144m180m
Interest expenses--
Provision for income taxes6m12m
Operating expenses180m225m
Income before taxes46m34m
Net income available to common shareholders40m21m
0.810.44
Net interest income2m7m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.780.43
Free cash flow per share0.4549-0.6778
Book value/share6.64017.7519
Debt equity ratio0.081360.08153

Balance sheet

20222023
Current assets312m365m
Current liabilities52m65m
Total capital332m386m
Total debt31m36m
Total equity332m386m
Total non current liabilities--
Loans--
Total assets415m489m
Total liabilities--
Cash and cash equivalents86m183m
Common stock48m49m

Cash flow

20222023
Cash at beginning of period200m86m
Cash dividends paid--
18m-4m
Investments (gains) losses-156m74m
86m183m
Net income--
36m15m
-18m-18m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.